Inhibition of renal sodium-glucose cotransport with empagliflozin lowers fasting plasma glucose and improves β-cell function in subjects with impaired fasting glucose
Profundice en los temas de investigación de 'Inhibition of renal sodium-glucose cotransport with empagliflozin lowers fasting plasma glucose and improves β-cell function in subjects with impaired fasting glucose'. En conjunto forman una huella única.